A Study to Evaluate the Esophageal Stenosis Inhibition Effects of CLS2702C/CLS2702D After Endoscopic Submucosal Dissection (ESD) in Patients With Superficial Esophageal Cancer in the Steroid Administration Risk Group
Clinical trial NCT04689594 · TERMINATED
Trial details
- NCT number
- NCT04689594
- Sponsor
- CellSeed Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2023-12-20
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.